Status:
COMPLETED
Measuring the Impact of Real Time fMRI Neurofeedback in Borderline Personality Disorder
Lead Sponsor:
Yale University
Collaborating Sponsors:
AE Foundation
Central Institute of Mental Health, Mannheim
Conditions:
Borderline Personality Disorder
Eligibility:
All Genders
18-50 years
Phase:
NA
Brief Summary
This study will test the impacts of real time fMRI neurofeedback in patients with Borderline Personality Disorder. This is a pilot study in a small number of people enrolled in clinical programs at Ya...
Eligibility Criteria
Inclusion
- enrolled in YNHH DBT-IOP
- must meet specific clinical criteria
- Inclusion in Experimental group requires participants meet standard safety and quality control requirements for MR scanning
- For female participants, not pregnant and willing to use a reliable method of contraception during the study
Exclusion
- IQ\<70
- vision problem not able to be corrected to normal range
- medication changes w/in one month
- Lifetime hx of schizophrenia, schizoaffective d/o, bipolar I disorder.
- illicit substance use within 7 days of MRI scans
- taking scheduled opiates
- taking scheduled benzodiazepines
- taking scheduled anti-histamines
- history of seizures
- significant current or past neurologic illness
- BMI \< 16.5
Key Trial Info
Start Date :
November 15 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 7 2022
Estimated Enrollment :
3 Patients enrolled
Trial Details
Trial ID
NCT04306341
Start Date
November 15 2020
End Date
October 7 2022
Last Update
May 22 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Connecticut Mental Health Center
New Haven, Connecticut, United States, 06519